Multiple Origins of Mutations in the mdr1 Gene—A Putative Marker of Chloroquine Resistance in P. vivax
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This high frequency has been verified by previous studies carried out by our group in Brazilian endemic areas [26,50], as well as by other authors analyzing samples from Africa [51], South America [50] and Southeast Asia [19], indicating the fixation of T958M in parasitic populations of P. vivax circulating in Brazil and in the world.”
From Are pvcrt-o and pvmdr1 Gene Mutations Associated with Plasmodium vivax Chloroquine-Resistant Parasites? (2024) · cites this paper as [51]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- AS ALVING, 1953, Korean vivax malaria. II. Curative treatment with pamaquine and primaquine, Am J Trop Med Hyg, 2, 970, 10.4269/ajtmh.1953.2.970 · doi:10.4269/ajtmh.1953.2.970
- AS ALVING, 1960, Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report, Bull World Health Organ, 22, 621
- FJ Lopez-Antunano, 1999, Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?, Salud Publica Mex, 41, 410, 10.1590/S0036-36341999000500010 · doi:10.1590/s0036-36341999000500010
- KH Rieckmann, 1989, Plasmodium vivax resistance to chloroquine?, Lancet, 2, 1183, 10.1016/S0140-6736(89)91792-3 · DOI · Paper page
- JK Baird, 2009, Resistance to therapies for infection by Plasmodium vivax, Clin Microbiol Rev, 22, 508, 10.1128/CMR.00008-09 · DOI · Paper page
- RN Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
- PG Bray, 2005, Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum, Biochem Pharmacol, 70, 1158, 10.1016/j.bcp.2005.07.021 · doi:10.1016/j.bcp.2005.07.021
- T Nomura, 2001, Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria, J Infect Dis, 183, 1653, 10.1086/320707 · DOI
- A Djimde, 2001, A molecular marker for chloroquine-resistant falciparum malaria, N Engl J Med, 344, 257, 10.1056/NEJM200101253440403 · DOI · Paper page
- DA Fidock, 2000, Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance, Mol Cell, 6, 861, 10.1016/S1097-2765(05)00077-8 · doi:10.1016/s1097-2765(05)00077-8 · Paper page
- R Suwanarusk, 2007, Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms, PLoS ONE, 2, e1089, 10.1371/journal.pone.0001089 · DOI · Paper page
- MT Duraisingh, 2005, Contribution of the pfmdr1 gene to antimalarial drug-resistance, Acta Trop, 94, 181, 10.1016/j.actatropica.2005.04.008 · DOI · Paper page
- MT Duraisingh, 2000, The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin, Mol Biochem Parasitol, 108, 13, 10.1016/S0166-6851(00)00201-2 · DOI · Paper page
- S Brega, 2005, Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity, J Infect Dis, 191, 272, 10.1086/426830 · DOI
- M Imwong, 2008, Gene amplification of the multidrug resistance 1 gene of Plasmodium vivax isolates from Thailand, Laos, and Myanmar, Antimicrob Agents Chemother, 52, 2657, 10.1128/AAC.01459-07 · doi:10.1128/aac.01459-07
- SJ Foote, 1990, Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum, Nature, 345, 255, 10.1038/345255a0 · DOI
- S Brega, 2004, Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates, Antimicrob Agents Chemother, 48, 2581, 10.1128/AAC.48.7.2581-2587.2004 · doi:10.1128/aac.48.7.2581-2587.2004
- C Barnadas, 2008, Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes, Antimicrob Agents Chemother, 52, 4233, 10.1128/AAC.00578-08 · DOI
- R Suwanarusk, 2008, Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax, J Infect Dis, 198, 1558, 10.1086/592451 · DOI · Paper page
- BE Gama, 2009, Characterisation of pvmdr1 and pvdhfr genes associated with chemoresistance in Brazilian Plasmodium vivax isolates, Mem Inst Oswaldo Cruz, 104, 1009, 10.1590/S0074-02762009000700012 · DOI · Paper page
- YK Kim, 2011, Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis, Am J Trop Med Hyg, 84, 532, 10.4269/ajtmh.2011.10-0486 · doi:10.4269/ajtmh.2011.10-0486
- F Lu, 2011, Genetic polymorphism in pvmdr1 and pvcrt-o genes in relation to in vitro drug susceptibility of Plasmodium vivax isolates from malaria-endemic countries, Acta Trop, 117, 69, 10.1016/j.actatropica.2010.08.011 · DOI · Paper page
- P Orjuela-Sanchez, 2009, Analysis of single-nucleotide polymorphisms in the crt-o and mdr1 genes of Plasmodium vivax among chloroquine-resistant isolates from the Brazilian Amazon region, Antimicrob Agents Chemother, 53, 3561, 10.1128/AAC.00004-09 · DOI
- S Nair, 2003, A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites, Mol Biol Evol, 20, 1526, 10.1093/molbev/msg162 · DOI · Paper page
- RJ Pearce, 2009, Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria, PLoS Med, 6, e1000055, 10.1371/journal.pmed.1000055 · DOI · Paper page
- JC Wootton, 2002, Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum, Nature, 418, 320, 10.1038/nature00813 · DOI · Paper page
- C Roper, 2004, Intercontinental spread of pyrimethamine-resistant malaria, Science, 305, 1124, 10.1126/science.1098876 · DOI · Paper page
- VN Hawkins, 2008, Multiple origins of resistance-conferring mutations in Plasmodium vivax dihydrofolate reductase, Malar J, 7, 72, 10.1186/1475-2875-7-72 · doi:10.1186/1475-2875-7-72
- VN Hawkins, 2009, Assessment of the origins and spread of putative resistance-conferring mutations in Plasmodium vivax dihydropteroate synthase, Am J Trop Med Hyg, 81, 348, 10.4269/ajtmh.2009.81.348 · doi:10.4269/ajtmh.2009.81.348
- ML Schousboe, 2014, Global and local genetic diversity at two microsatellite loci in Plasmodium vivax parasites from Asia, Africa and South America, Malar J, 13, 392, 10.1186/1475-2875-13-392 · doi:10.1186/1475-2875-13-392
- T Leslie, 2007, Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial, JAMA, 297, 2201, 10.1001/jama.297.20.2201 · doi:10.1001/jama.297.20.2201
- T Leslie, 2008, A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, Pakistan, PLoS ONE, 3, e2861, 10.1371/journal.pone.0002861 · DOI
- ML Schousboe, 2007, Island-wide differences in single nucleotide polymorphisms of the P, Malar J, 6
- S Ranjitkar, 2011, Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal, Malar J, 10, 75, 10.1186/1475-2875-10-75 · DOI
- NB Gadalla, 2011, Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine, Antimicrob Agents Chemother, 55, 5408, 10.1128/AAC.05102-11 · DOI
- G Benson, 1999, Tandem repeats finder: a program to analyze DNA sequences, Nucleic Acids Res, 27, 573, 10.1093/nar/27.2.573 · DOI · Paper page
- L Excoffier, 2005, Arlequin (version 3.0): an integrated software package for population genetics data analysis, Evol Bioinform Online, 1, 47, 10.1177/117693430500100003 · DOI · Paper page
- JM Sa, 2005, Plasmodium vivax: allele variants of the mdr1 gene do not associate with chloroquine resistance among isolates from Brazil, Papua, and monkey-adapted strains, Exp Parasitol, 109, 256, 10.1016/j.exppara.2004.12.005 · DOI
- JE Taylor, 2013, The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas, Mol Biol Evol, 30, 2050, 10.1093/molbev/mst104 · DOI
- N Chen, 2005, Origin and dissemination of chloroquine-resistant Plasmodium falciparum with mutant pfcrt alleles in the Philippines, Antimicrob Agents Chemother, 49, 2102, 10.1128/AAC.49.5.2102-2105.2005 · doi:10.1128/aac.49.5.2102-2105.2005
- JF Cortese, 2002, Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America, J Infect Dis, 186, 999, 10.1086/342946 · DOI · Paper page
- R Pearce, 2005, Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum, Mol Biol Evol, 22, 1834, 10.1093/molbev/msi177 · DOI
- C Roper, 2003, Antifolate antimalarial resistance in southeast Africa: a population-based analysis, Lancet, 361, 1174, 10.1016/S0140-6736(03)12951-0 · DOI · Paper page
- DE Neafsey, 2012, The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum, Nat Genet, 44, 1046, 10.1038/ng.2373 · DOI · Paper page
Cited by
Abreu-Fernandes, R. D., Almeida-de-Oliveira, N. K., de Lavigne Mello, A. R., Queiroz, L. T. D., Barros, J. D. A., Baptista, B. D. O., Oliveira-Ferreira, J., Souza, R. M. D., Pratt-Riccio, L. R., Brasil, P., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12010141 · Cited by 5
Metadata
- Authors
- Schousboe, M. L., Ranjitkar, S., Rajakaruna, R. S., Amerasinghe, P. H., Morales, F., Pearce, R., Ord, R., Leslie, T., Rowland, M., Gadalla, N. B., Konradsen, F., Bygbjerg, I. C., Roper, C., & Alifrangis, M.
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-11-05
- Volume
- 9
- Issue
- 11
- Pages
- e0004196
- ISSN
- 1935-2735
- Cited by
- 35
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.